Page results
-
Women’s Health Psychological Services (WHPS) is an essential dimension of ethical, holistic and quality care for women and their families.
-
The Transforming End of Life Care Team provides support and training for staff throughout UCLH to deliver the best end-of-life care.
-
UCLH has released a statement congratulating Carrie Symonds and prime minister Boris Johnson on the birth of their son. There will be no further comment.
-
There are many ways that UCLH can communicate with you about your care. You can set your preferences regarding what you would like to be informed about, and how you wish to receive notifications from your MyCare UCLH account.
-
The National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH NHS Foundation Trust, has been reaccredited under the prestigious Royal College of Anaesthetists (RCoA) Anaesthesia Clinical Services Accreditation (ACSA) demonstrating the hospital anaesthetists’ commitment to patient safety and excellence of care.
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Information for patients having a mediastinoscopy / mediastinotomy procedure.
-
Information for patients having a surgery via median sternotomy.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
File results
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2019/16 Antenatal unit questionnaire
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI2017328 Use of variable rate intravenous insulin infusion